Related references
Note: Only part of the references are listed.Co-expression of self-cleaved multiple proteins derived from Porcine Reproductive and Respiratory Syndrome Virus by bi-cistronic and tri-cistronic DNA vaccines
Sochanwattey Meas et al.
PROTEIN EXPRESSION AND PURIFICATION (2021)
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
Rebecca L. Brocato et al.
NPJ VACCINES (2021)
A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation
Hyein Jeong et al.
FRONTIERS IN IMMUNOLOGY (2021)
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
Eakachai Prompetchara et al.
PLOS ONE (2021)
An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines
Yan Guo et al.
MBIO (2021)
Methods to improve the immunogenicity of plasmid DNA vaccines
Dalinda Eusebio et al.
DRUG DISCOVERY TODAY (2021)
INDIA'S DNA COVID VACCINE IS A WORLD FIRST - MORE ARE COMING
Smriti Mallapaty
NATURE (2021)
Nano-Microparticle Platforms in Developing Next-Generation Vaccines
Giuseppe Cappellano et al.
VACCINES (2021)
ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer
Bing Sun et al.
JOURNAL OF MATERIALS CHEMISTRY B (2021)
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
Taufik Momin et al.
ECLINICALMEDICINE (2021)
Neutralizing Antibody Responses in COVID-19 Convalescent Sera
William T. Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial
Pablo Tebas et al.
ECLINICALMEDICINE (2021)
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques
Yuzhong Li et al.
EMERGING MICROBES & INFECTIONS (2021)
IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses
Ji Won Han et al.
JOURNAL OF HEPATOLOGY (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Current Status of COVID-19 (Pre)Clinical Vaccine Development
Tingting Ye et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
DNA vaccines: prime time is now
Ebony N. Gary et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan et al.
CELL (2020)
Role of microRNAs in Staphylococcus aureus infection: Potential biomarkers and mechanism
Rasoul Mirzaei et al.
IUBMB LIFE (2020)
PRELIMINARY EVALUATION OF A NOVEL CORONAVIRUS VACCINE (CORVAX) USING ELECTROPORATION OF PLASMID DNA ENCODING A STABILIZED PREFUSION SARS-COV-2 SPIKE PROTEIN ALONE OR WITH TRANSFECTION OF PLASMID IL-12
Shawn Jensen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
Swati Jain et al.
VACCINES (2020)
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
Rasoul Mirzaei et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Pablo Tebas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
Margaret A. Liu
VACCINES (2019)
Current Progress of Avian Vaccines Against West Nile Virus
Nereida Jimenez de Oya et al.
VACCINES (2019)
Nucleic acid aptamers in diagnosis of colorectal cancer
Yaghoub Ahmadyousefi et al.
BIOCHIMIE (2019)
Production of lentiviral vectors using novel, enzymatically produced, linear DNA
Rajvinder Karda et al.
GENE THERAPY (2019)
The Human Immune System against Staphylococcus epidermidis
Mirzaei Rasoul et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2019)
A Review of DNA Vaccines Against Influenza
Leo Yi Yang Lee et al.
FRONTIERS IN IMMUNOLOGY (2018)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Polymers for DNA Vaccine Delivery
Mingming Zhang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Polymers for DNA Vaccine Delivery
Mingming Zhang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals
Jiamiao Lu et al.
MOLECULAR THERAPY (2017)
Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma
A. N. Meleshko et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Molecular Adjuvants for DNA Vaccines
Lei Li et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2017)
Clinical potential of electroporation for gene therapy and DNA vaccine delivery
Laure Lambricht et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Micro- and nanoparticulates for DNA vaccine delivery
Eric Farris et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Development of a Targeted anti-HER2 scFv Chimeric Peptide for Gene Delivery into HER2-Positive Breast Cancer Cells
Roya Cheraghi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
S. H. T. Jorritsma et al.
VACCINE (2016)
Effective gene delivery into adipose-derived stem cells: transfection of cells in suspension with the use of a nuclear localization signal peptide-conjugated polyethylenimine
Eulsoon Park et al.
CYTOTHERAPY (2015)
Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression
Simone Krinner et al.
HUMAN GENE THERAPY (2015)
Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials
Xia Jin et al.
VACCINE (2015)
Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
Veronica L. Scott et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants
Xiaohu H. Hou et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2015)
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
Uzma N. Sarwar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
Thomas Grunwald et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2015)
Production and purification of plasmid DNA vaccines: is there scope for further innovation?
Alex Xenopoulos et al.
EXPERT REVIEW OF VACCINES (2014)
Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines
A. A. Walters et al.
GENE THERAPY (2014)
Nanoparticles for DNA Vaccine Delivery
Muhammad Ali A. Shah et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients
Lisa H. Butterfield et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Vectorology and Factor Delivery in Induced Pluripotent Stem Cell Reprogramming
Kejin Hu
STEM CELLS AND DEVELOPMENT (2014)
Safety and efficacy of DNA vaccines Plasmids vs. minicircles
Sofia Stenler et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
Erin K. Quirk et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Minicircle DNA Vectors Achieve Sustained Expression Reflected by Active Chromatin and Transcriptional Level
Lia E. Gracey Maniar et al.
MOLECULAR THERAPY (2013)
DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial
Barney S. Graham et al.
PLOS ONE (2013)
Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter
B. Duan et al.
THERIOGENOLOGY (2012)
Development of a DNA vaccine against chicken anemia virus by using a bicistronic vector expressing VP1 and VP2 proteins of CAV
Hassan Moeini et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2011)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
Sandhya Vasan et al.
PLOS ONE (2011)
Surveillance for West Nile Virus and Vaccination of Free-Ranging Island Scrub-Jays (Aphelocoma insularis) on Santa Cruz Island, California
Walter M. Boyce et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2011)
FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
Dennis M. Klinman et al.
VACCINE (2010)
Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production
James A. Williams et al.
BIOTECHNOLOGY ADVANCES (2009)
DNA vaccines in veterinary use
Laurel Redding et al.
EXPERT REVIEW OF VACCINES (2009)
DNA vaccine manufacture: scale and quality
Ying Cai et al.
EXPERT REVIEW OF VACCINES (2009)
DNA vaccines for biodefense
Lesley C. Dupuy et al.
EXPERT REVIEW OF VACCINES (2009)
Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes
Praneet Opanasopit et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence
Jing Ni et al.
VACCINE (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
Julie E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Targeted delivery to the nucleus
Colin W. Pouton et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
DNA immunisation with minimalistic expression constructs
S Moreno et al.
VACCINE (2004)
Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle
AR Brooks et al.
JOURNAL OF GENE MEDICINE (2004)
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
Z Wang et al.
GENE THERAPY (2004)
Microneedles for transdermal drug delivery
MR Prausnitz
ADVANCED DRUG DELIVERY REVIEWS (2004)
Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein
L Vaysse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses
S Sudowe et al.
MOLECULAR THERAPY (2003)
Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80):: Adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4
AA Siddiqui et al.
INFECTION AND IMMUNITY (2003)
Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin
R Ross et al.
GENE THERAPY (2003)
Immunization with DNA through the skin
KK Peachman et al.
METHODS (2003)
DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice
L López-Fuertes et al.
VACCINE (2002)
Epidermal Langerhans cell-targeted gene expression by a dectin-2 promoter
M Bonkobara et al.
JOURNAL OF IMMUNOLOGY (2001)
Skin-targeted gene transfer using in vivo electroporation
H Maruyama et al.
GENE THERAPY (2001)
The challenge of gene therapy and DNA delivery
AJ Phillips
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery
YK Oh et al.
VACCINE (2001)
A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA
F Schakowski et al.
MOLECULAR THERAPY (2001)
A regulated, NFκB-assisted import of plasmid DNA into mammalian cell nuclei
A Mesika et al.
MOLECULAR THERAPY (2001)
Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice
BJ Ledwith et al.
INTERVIROLOGY (2000)
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
G Widera et al.
JOURNAL OF IMMUNOLOGY (2000)
Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein
H Kaneko et al.
VIROLOGY (2000)
Share Paper
